Steward Partners Investment Advisory, LLC Novo Cure LTD Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 100 shares of NVCR stock, worth $1,759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 449
77.73%
Holding current value
$1,759
Previous $13,000
92.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
78MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$213 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$198 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$157 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$97.1 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$91.7 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.85B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...